Cosmo Pharmaceuticals Investor Presentation September 2022

Cosmo Pharmaceuticals presents its corporate strategy and innovation initiatives focused on developing drug candidates for IBD disease treatment. The presentation outlines the company's research and development activities, commercialization partnerships, and future growth plans in the pharmaceutical sector.